Medicure (MCUJF) Non-Current Deferred Tax Liability (2016 - 2017)

Medicure (MCUJF) recorded quarterly Non-Current Deferred Tax Liability of $478968.2 in Q4 2017, down 98.22% quarter-over-quarter from $26.9 million in Q3 2017, and down 98.33% on a YoY basis from $28.6 million in Q4 2016.

Medicure (MCUJF) Non-Current Deferred Tax Liability (2016 - 2017) Analysis & Trends

Medicure's Non-Current Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $478968.2 for Q4 2017.

  • In Q4 2017, Non-Current Deferred Tax Liability fell 98.33% year-over-year to $478968.2; the TTM figure through Dec 2017 stood at $478968.2 (down 98.33% YoY), while the FY2017 annual figure was $469025.3, down 98.36% from the prior year.
  • Non-Current Deferred Tax Liability was $478968.2 for Q4 2017 at Medicure, down from $26.9 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $28.6 million in Q4 2016 to a low of $478968.2 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Medicure - - 2.57 Mn

Historic Data

Download Data
DateValue
Dec 31, 2017 478,968.19
Dec 31, 2017 478,968.19
Sep 30, 2017 26.86 Mn
Sep 30, 2017 26.86 Mn
Jun 30, 2017 26.25 Mn
Jun 30, 2017 26.25 Mn
Mar 31, 2017 27.06 Mn
Mar 31, 2017 27.06 Mn
Dec 31, 2016 28.60 Mn
Dec 31, 2016 28.60 Mn